glp 1 glucagon Glucagon-like peptide-1 Cardiovascular effects of Glucagon-like peptide

Mounjaro (tirzepatide) product information

[DOI] [PubMed] [Google Scholar] 126.Knop FK, Aroda VR, do Vale RD, et al

Insurance companies have largely classified Ozempic and other GLP-1 receptor agonists as upper-tier prescriptions, meaning that they typically provide less coverage for them

After standardizing for various factors, GLP1 RA compared with metformin was associated with reduced 1year risk of addon glucoselowering treatment in patients with prediabetes (1year risk ratio [RR]: 0.27, 95% confidence interval [CI]: 0.100.44) and diabetes (RR: 0.67, 95% CI: 0.370.98)

doi: 10.2337/dc23-S002

Doses above 2 g/day are not commonly used in practice for this indication